Surgalign sells Coflex product to Xtant for $17M

By

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million (press release)
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device
Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surger...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.